Nasus Pharma Ltd (NSRX) stock
NSRXNYSEPharmaceutical PreparationsFiscal year ends December 31
$2.70+0.09 (+3.45%)
Close on Nov 18, 2026Market cap $24.34MP/E –Yield –
Nasus Pharma net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2025 it was -$5.86M.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$5.86M | – |
| FY2024 | Dec 31, 2024 | -$1.53M | – |
| FY2023 | Dec 31, 2023 | -$1.05M | – |
See a number that looks wrong?